EHMT2 and hepatocellular carcinoma: As an inhibitor of histone methyltransferase G9a, studies have shown that CM-272 can effectively reduce the di-methylation level of lysine 9 on histone H3 in hepatoma cells by inhibiting G9a and downregulating G9a expression (Bárcena‐Varela et al., 2019).